[go: up one dir, main page]

AU3542697A - Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate - Google Patents

Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate

Info

Publication number
AU3542697A
AU3542697A AU35426/97A AU3542697A AU3542697A AU 3542697 A AU3542697 A AU 3542697A AU 35426/97 A AU35426/97 A AU 35426/97A AU 3542697 A AU3542697 A AU 3542697A AU 3542697 A AU3542697 A AU 3542697A
Authority
AU
Australia
Prior art keywords
carbazolyl
oxy
active ingredient
pharmaceutical formulations
topical application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35426/97A
Inventor
Hans-Georg Opitz
Gisbert Sponer
Heinrich Woog
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19628335A external-priority patent/DE19628335A1/en
Priority claimed from DE1997124752 external-priority patent/DE19724752A1/en
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of AU3542697A publication Critical patent/AU3542697A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU35426/97A 1996-07-13 1997-07-08 Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate Abandoned AU3542697A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19628335 1996-07-13
DE19628335A DE19628335A1 (en) 1996-07-13 1996-07-13 Use of topical (carbazolyl-oxy)-propanolamine derivatives
DE1997124752 DE19724752A1 (en) 1997-04-24 1997-04-24 Use of carbazol-4-yl-oxy-propanol-amine derivative
DE19724752 1997-04-24
PCT/EP1997/003602 WO1998002157A1 (en) 1996-07-13 1997-07-08 Pharmaceutical formulations for topical application containing as an active ingredient a carbazolyl-(4)-oxy-propanol amine derivate

Publications (1)

Publication Number Publication Date
AU3542697A true AU3542697A (en) 1998-02-09

Family

ID=26027495

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35426/97A Abandoned AU3542697A (en) 1996-07-13 1997-07-08 Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate

Country Status (3)

Country Link
EP (1) EP0910374A1 (en)
AU (1) AU3542697A (en)
WO (1) WO1998002157A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002528118A (en) 1998-11-04 2002-09-03 ジェンセット Genomic and total cDNA sequences of APM1 specific to human adipocytes and their biallelic markers
US20050261355A1 (en) 2002-06-27 2005-11-24 Sb Pharmco Puerto Rico Inc., Carvedilol hydobromide
CA2492060C (en) 2002-06-27 2011-11-01 Sb Pharmco Puerto Rico Inc. Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
US7750036B2 (en) 2003-11-25 2010-07-06 Sb Pharmco Puerto Rico Inc. Carvedilol salts, corresponding compositions, methods of delivery and/or treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2337154C2 (en) * 1973-07-18 1986-04-24 Schering AG, 1000 Berlin und 4709 Bergkamen New carbazole derivatives
DE3319027A1 (en) * 1983-05-26 1984-11-29 Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR PRODUCING OPTICALLY ACTIVE CARBAZOL DERIVATIVES, NEW R- AND S-CARBAZOL DERIVATIVES, AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
ZA938897B (en) * 1992-12-01 1994-08-01 Smithkline Beecham Corp Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds

Also Published As

Publication number Publication date
EP0910374A1 (en) 1999-04-28
WO1998002157A1 (en) 1998-01-22

Similar Documents

Publication Publication Date Title
EP0727217A3 (en) Pharmaceutical composition containing god-type ellagitannin as active ingredient
AU5945396A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
AU7547196A (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
AU2595697A (en) Compounds and compositions for delivering active agents
AUPM969994A0 (en) Equine anthelmintic formulations
HUP9601566A3 (en) Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component
HUP0000568A3 (en) Gel formulations for topical drug delivery containing 4-amino-2-ethoxymethyl-alpha, alpha-dimethyl-1h-imidazo[4,5-c]quinoline-1-ethanol
AU4256996A (en) Parasiticide formulations suitable for dermal application
HUP0000575A3 (en) Novel formulation comprising budesonid as active indegredient
MA26507A1 (en) AEROSOL PHARMACEUTICAL COMPOSITIONS
HUP9900617A3 (en) Novel indole-, indoline- or tetrahydrokinoline derivatives as acat and lipid peroxidation inhibitors, use thereof, pharmaceutical compositions containing these compounds
HU9802795D0 (en) Pharmaceutical compositions containing more active components
AU1689999A (en) Medicinal composition for percutaneous administration
EP1090912A4 (en) Amino acid derivatives and drugs containing the same as the active ingredient
NZ318391A (en) Fungicidal compositions comprising fenazaquine as an active substance
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
AU3453897A (en) Medicinal cyclosporin-a aerosol solution formulation
AU3261297A (en) New insecticide formulations
AU4232997A (en) Chlorofluorocarbon-free mometasone furoate aerosol formulations
AU1354495A (en) Formulations for orally administered pharmaceutical agents
AU2080695A (en) Pharmaceutical inhalation compositions containing a solid active ingredient
AU5326298A (en) Pharmaceutical compositions containing N-sulphonylindoline derivatives
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin
AU3542697A (en) Pharmaceutical formulations for topical application containing as an active ingredient carbazolyl-(4)-oxy-propanol amine derivate
EP0978287A4 (en) MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT